Cambridgene graduated from Cambridge Social Ventures in November 2015.
Cambridgene’s mission is to improve people’s lives through precision medicines.
Cambridgene unlocks the power of multiomics to accelerate and de-risk pharmaceutical research and development. Our advanced research workflows and genetic profiling solutions accelerate the development and delivery of precision medicines. We have experience gained from developing solutions for analysing thousands of patients in academic research institutions.
Cambridgene enables pharmaceutical companies to deploy the highest quality genomic analysis combined with the best data representation to support decision-making and stratification of results.